Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2026 07:00 ET | Source: SATO Oyj

SATOn työntekijäkokemus vahvistui – vaikutukset näkyvät myös asiakkaiden arjessa

Satolaisten halukkuus suositella omaa työpaikkaansa nousi lähes neljällä pisteellä (67). Nouseva trendi näkyy myös asukastyytyväisyydessä.
May 08, 2026 07:00 ET | Source: SATO Oyj

SATO’s employee experience strengthened – positive effects visible in customers’ everyday lives

Employees’ willingness to recommend their workplace increased by almost four points (67). The upward trend is also visible in customer satisfaction.
May 08, 2026 02:00 ET | Source: SATO Oyj

SATO Oyj:n osavuosikatsaus 1.1.–31.3.2026: SATOn kasvu jatkuu

SATOn kasvu jatkui ensimmäisellä vuosineljänneksellä.
May 08, 2026 02:00 ET | Source: SATO Oyj

SATO Corporation Interim Report 1 January–31 March 2026: SATO’s growth continues

SATO's growth continued during the first quarter of the year.
February 09, 2024 02:00 ET | Source: SATO Oyj

SATOn tilinpäätöstiedote 2023: Haastava vuosi – asiakastyytyväisyys parani

SATO Oyj, Pörssitiedote 9.2.2024 klo 9.00Yhteenveto ajalta 1.1.-31.12.2023 (1.1.-31.12.2022) Taloudellinen vuokrausaste heikkeni ja oli 94,9 % (95,2).Liikevaihto oli 288,4 milj. €...
February 09, 2024 02:00 ET | Source: SATO Oyj

SATO Corporation’s Financial Statements Bulletin 2023: Challenging year – customer satisfaction improved

SATO Corporation, Stock Exchange Release 9 February 2024 at 9:00 am Highlights January–December 2023 (January–December 2022) The economic occupancy rate decreased and was 94.9% (95.2).Net sales...
December 21, 2022 08:00 ET | Source: Novan, Inc.

EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan

DURHAM, N.C., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that EPI Health, LLC, a fully consolidated subsidiary of Novan, has entered...
April 03, 2020 08:15 ET | Source: Novan, Inc.

Novan Receives Verbal Guidance from FDA for SB206 and Announces Sato Program Advancement

Per verbal guidance, FDA to consider one additional pivotal trialFDA-generated minutes expected on or before May 1, 2020Sato Pharmaceutical to begin start-up of Phase 1 trial in Japan MORRISVILLE,...
January 14, 2020 07:00 ET | Source: SATO America

SATO Goes Further Beyond Expectations with Refresh of Universal Industrial Thermal Printer Line

Tokyo, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Tokyo, January 14, 2020 – SATO, a global pioneer in the development of auto-ID and labeling solutions today launched CL4NX Plus, a best in class thermal...
March 19, 2019 09:00 ET | Source: Novan, Inc.

Novan and Sato Advance Japan Market and Dermatology Partnership

Dr. Elizabeth Messersmith named chairperson of the Sato and Novan Joint CommitteeSimultaneous clinical development progress for SB206 in Japan and US underwayNovan receives second installment of $4.5...